Global Dermatology OTC Medications Market Insights and Forecast to 2027

Report ID: 863412 | Published Date: Jan 2025 | No. of Page: 146 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Dermatology OTC Medications Product Introduction
    1.2 Market by Type
        1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
        1.4.2 External Use
        1.4.3 Oral
    1.3 Market by Application
        1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Dermatology OTC Medications Sales Estimates and Forecasts 2016-2027
    2.2 Global Dermatology OTC Medications Revenue Estimates and Forecasts 2016-2027
    2.3 Global Dermatology OTC Medications Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Dermatology OTC Medications Regions by Sales
        2.4.1 Global Top Dermatology OTC Medications Regions by Sales (2016-2021)
        2.4.2 Global Top Dermatology OTC Medications Regions by Sales (2022-2027)
    2.5 Global Top Dermatology OTC Medications Regions by Revenue
        2.5.1 Global Top Dermatology OTC Medications Regions by Revenue (2016-2021)
        2.5.2 Global Top Dermatology OTC Medications Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dermatology OTC Medications Sales by Manufacturers
        3.1.1 Global Top Dermatology OTC Medications Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Sales in 2020
    3.2 Global Dermatology OTC Medications Revenue by Manufacturers
        3.2.1 Global Top Dermatology OTC Medications Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020
    3.3 Global Dermatology OTC Medications Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dermatology OTC Medications Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Dermatology OTC Medications Sales by Type
        4.1.1 Global Dermatology OTC Medications Historical Sales by Type (2016-2021)
        4.1.2 Global Dermatology OTC Medications Forecasted Sales by Type (2022-2027)
        4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    4.2 Global Dermatology OTC Medications Revenue by Type
        4.2.1 Global Dermatology OTC Medications Historical Revenue by Type (2016-2021)
        4.2.2 Global Dermatology OTC Medications Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    4.3 Global Dermatology OTC Medications Price by Type
        4.3.1 Global Dermatology OTC Medications Price by Type (2016-2021)
        4.3.2 Global Dermatology OTC Medications Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Dermatology OTC Medications Sales by Application
        5.1.1 Global Dermatology OTC Medications Historical Sales by Application (2016-2021)
        5.1.2 Global Dermatology OTC Medications Forecasted Sales by Application (2022-2027)
        5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    5.2 Global Dermatology OTC Medications Revenue by Application
        5.2.1 Global Dermatology OTC Medications Historical Revenue by Application (2016-2021)
        5.2.2 Global Dermatology OTC Medications Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    5.3 Global Dermatology OTC Medications Price by Application
        5.3.1 Global Dermatology OTC Medications Price by Application (2016-2021)
        5.3.2 Global Dermatology OTC Medications Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Dermatology OTC Medications Market Size by Type
        6.1.1 North America Dermatology OTC Medications Sales by Type (2016-2027)
        6.1.2 North America Dermatology OTC Medications Revenue by Type (2016-2027)
    6.2 North America Dermatology OTC Medications Market Size by Application
        6.2.1 North America Dermatology OTC Medications Sales by Application (2016-2027)
        6.2.2 North America Dermatology OTC Medications Revenue by Application (2016-2027)
    6.3 North America Dermatology OTC Medications Market Size by Country
        6.3.1 North America Dermatology OTC Medications Sales by Country (2016-2027)
        6.3.2 North America Dermatology OTC Medications Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dermatology OTC Medications Market Size by Type
        7.1.1 Europe Dermatology OTC Medications Sales by Type (2017-2027)
        7.1.2 Europe Dermatology OTC Medications Revenue by Type (2017-2027)
    7.2 Europe Dermatology OTC Medications Market Size by Application
        7.2.1 Europe Dermatology OTC Medications Sales by Application (2017-2027)
        7.2.2 Europe Dermatology OTC Medications Revenue by Application (2017-2027)
    7.3 Europe Dermatology OTC Medications Market Size by Country
        7.3.1 Europe Dermatology OTC Medications Sales by Country (2017-2027)
        7.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dermatology OTC Medications Market Size by Type
        8.1.1 Asia Pacific Dermatology OTC Medications Sales by Type (2018-2027)
        8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Type (2018-2027)
    8.2 Asia Pacific Dermatology OTC Medications Market Size by Application
        8.2.1 Asia Pacific Dermatology OTC Medications Sales by Application (2018-2027)
        8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Application (2018-2027)
    8.3 Asia Pacific Dermatology OTC Medications Market Size by Region
        8.3.1 Asia Pacific Dermatology OTC Medications Sales by Region (2018-2027)
        8.3.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dermatology OTC Medications Market Size by Type
        9.1.1 Latin America Dermatology OTC Medications Sales by Type (2019-2027)
        9.1.2 Latin America Dermatology OTC Medications Revenue by Type (2019-2027)
    9.2 Latin America Dermatology OTC Medications Market Size by Application
        9.2.1 Latin America Dermatology OTC Medications Sales by Application (2019-2027)
        9.2.2 Latin America Dermatology OTC Medications Revenue by Application (2019-2027)
    9.3 Latin America Dermatology OTC Medications Market Size by Country
        9.3.1 Latin America Dermatology OTC Medications Sales by Country (2019-2027)
        9.3.2 Latin America Dermatology OTC Medications Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Dermatology OTC Medications Market Size by Type
        6.1.1 Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Type (2016-2027)
    6.2 Middle East and Africa Dermatology OTC Medications Market Size by Application
        6.2.1 Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Application (2016-2027)
    6.3 Middle East and Africa Dermatology OTC Medications Market Size by Country
        6.3.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Bayer Dermatology OTC Medications Product Description
        11.1.5 Bayer Related Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 GSK Dermatology OTC Medications Product Description
        11.2.5 GSK Related Developments
    11.3 Teva
        11.3.1 Teva Corporation Information
        11.3.2 Teva Overview
        11.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Teva Dermatology OTC Medications Product Description
        11.3.5 Teva Related Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Corporation Information
        11.4.2 Johnson & Johnson Overview
        11.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Johnson & Johnson Dermatology OTC Medications Product Description
        11.4.5 Johnson & Johnson Related Developments
    11.5 Novartis
        11.5.1 Novartis Corporation Information
        11.5.2 Novartis Overview
        11.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Novartis Dermatology OTC Medications Product Description
        11.5.5 Novartis Related Developments
    11.6 Mylan
        11.6.1 Mylan Corporation Information
        11.6.2 Mylan Overview
        11.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Mylan Dermatology OTC Medications Product Description
        11.6.5 Mylan Related Developments
    11.7 Sun Pharmaceutical
        11.7.1 Sun Pharmaceutical Corporation Information
        11.7.2 Sun Pharmaceutical Overview
        11.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Description
        11.7.5 Sun Pharmaceutical Related Developments
    11.8 Aurobindo
        11.8.1 Aurobindo Corporation Information
        11.8.2 Aurobindo Overview
        11.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Aurobindo Dermatology OTC Medications Product Description
        11.8.5 Aurobindo Related Developments
    11.9 Galderma
        11.9.1 Galderma Corporation Information
        11.9.2 Galderma Overview
        11.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Galderma Dermatology OTC Medications Product Description
        11.9.5 Galderma Related Developments
    11.10 CR SANJIU
        11.10.1 CR SANJIU Corporation Information
        11.10.2 CR SANJIU Overview
        11.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 CR SANJIU Dermatology OTC Medications Product Description
        11.10.5 CR SANJIU Related Developments
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Bayer Dermatology OTC Medications Product Description
        11.1.5 Bayer Related Developments
    11.12 Lupin
        11.12.1 Lupin Corporation Information
        11.12.2 Lupin Overview
        11.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Lupin Product Description
        11.12.5 Lupin Related Developments
    11.13 Bausch Health
        11.13.1 Bausch Health Corporation Information
        11.13.2 Bausch Health Overview
        11.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Bausch Health Product Description
        11.13.5 Bausch Health Related Developments
    11.14 Cipla
        11.14.1 Cipla Corporation Information
        11.14.2 Cipla Overview
        11.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Cipla Product Description
        11.14.5 Cipla Related Developments
    11.15 Qilu Pharmaceutical
        11.15.1 Qilu Pharmaceutical Corporation Information
        11.15.2 Qilu Pharmaceutical Overview
        11.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Qilu Pharmaceutical Product Description
        11.15.5 Qilu Pharmaceutical Related Developments
    11.16 Almirall
        11.16.1 Almirall Corporation Information
        11.16.2 Almirall Overview
        11.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.16.4 Almirall Product Description
        11.16.5 Almirall Related Developments
    11.17 Lingrui
        11.17.1 Lingrui Corporation Information
        11.17.2 Lingrui Overview
        11.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
        11.17.4 Lingrui Product Description
        11.17.5 Lingrui Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Dermatology OTC Medications Value Chain Analysis
    12.2 Dermatology OTC Medications Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dermatology OTC Medications Production Mode & Process
    12.4 Dermatology OTC Medications Sales and Marketing
        12.4.1 Dermatology OTC Medications Sales Channels
        12.4.2 Dermatology OTC Medications Distributors
    12.5 Dermatology OTC Medications Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dermatology OTC Medications Industry Trends
    13.2 Dermatology OTC Medications Market Drivers
    13.3 Dermatology OTC Medications Market Challenges
    13.4 Dermatology OTC Medications Market Restraints

14 Key Findings in The Global Dermatology OTC Medications Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Dermatology OTC Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of External Use
    Table 3. Major Manufacturers of Oral
    Table 4. Global Dermatology OTC Medications Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 5. Global Dermatology OTC Medications Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
    Table 7. Global Dermatology OTC Medications Sales Market Share by Region (2016-2021)
    Table 8. Global Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
    Table 9. Global Dermatology OTC Medications Sales Market Share by Region (2022-2027)
    Table 10. Global Dermatology OTC Medications Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Dermatology OTC Medications Revenue Market Share by Region (2016-2021)
    Table 12. Global Dermatology OTC Medications Revenue by Region (2022-2027) & (US$ Million)
    Table 13. Global Dermatology OTC Medications Revenue Market Share by Region (2022-2027)
    Table 14. Global Dermatology OTC Medications Sales by Manufacturers (2016-2021) & (M Units)
    Table 15. Global Dermatology OTC Medications Sales Share by Manufacturers (2016-2021)
    Table 16. Global Dermatology OTC Medications Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 17. Global Dermatology OTC Medications Revenue Share by Manufacturers (2016-2021)
    Table 18. Dermatology OTC Medications Price by Manufacturers 2016-2021 (USD/Unit)
    Table 19. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2020)
    Table 21. Dermatology OTC Medications Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Dermatology OTC Medications Product Offered
    Table 23. Date of Manufacturers Enter into Dermatology OTC Medications Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 26. Global Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 27. Global Dermatology OTC Medications Sales Share by Type (2016-2021)
    Table 28. Global Dermatology OTC Medications Sales Share by Type (2022-2027)
    Table 29. Global Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 30. Global Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 31. Global Dermatology OTC Medications Revenue Share by Type (2016-2021)
    Table 32. Global Dermatology OTC Medications Revenue Share by Type (2022-2027)
    Table 33. Dermatology OTC Medications Price by Type (2016-2021) & (USD/Unit)
    Table 34. Global Dermatology OTC Medications Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 35. Global Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 36. Global Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 37. Global Dermatology OTC Medications Sales Share by Application (2016-2021)
    Table 38. Global Dermatology OTC Medications Sales Share by Application (2022-2027)
    Table 39. Global Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 40. Global Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 41. Global Dermatology OTC Medications Revenue Share by Application (2016-2021)
    Table 42. Global Dermatology OTC Medications Revenue Share by Application (2022-2027)
    Table 43. Dermatology OTC Medications Price by Application (2016-2021) & (USD/Unit)
    Table 44. Global Dermatology OTC Medications Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 45. North America Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 46. North America Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 47. North America Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 48. North America Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 49. North America Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 50. North America Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 51. North America Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 52. North America Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 53. North America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
    Table 54. North America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
    Table 55. North America Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
    Table 56. North America Dermatology OTC Medications Revenue by Country (2022-2027) & (US$ Million)
    Table 57. Europe Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 58. Europe Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 59. Europe Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 60. Europe Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 61. Europe Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 62. Europe Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 63. Europe Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 64. Europe Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 65. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
    Table 66. Europe Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
    Table 67. Europe Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
    Table 68. Europe Dermatology OTC Medications Revenue by Country (2022-2027) & (US$ Million)
    Table 69. Asia Pacific Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 70. Asia Pacific Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 71. Asia Pacific Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 72. Asia Pacific Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 73. Asia Pacific Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 74. Asia Pacific Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 75. Asia Pacific Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 77. Asia Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
    Table 78. Asia Pacific Dermatology OTC Medications Sales by Region (2022-2027) & (M Units)
    Table 79. Asia Pacific Dermatology OTC Medications Revenue by Region (2016-2021) & (US$ Million)
    Table 80. Asia Pacific Dermatology OTC Medications Revenue by Region (2022-2027) & (US$ Million)
    Table 81. Latin America Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 82. Latin America Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 83. Latin America Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 84. Latin America Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 85. Latin America Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 86. Latin America Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 87. Latin America Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 88. Latin America Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 89. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
    Table 90. Latin America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
    Table 91. Latin America Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
    Table 92. Latin America Dermatology OTC Medications Revenue by Country (2022-2027) & (US$ Million)
    Table 93. Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
    Table 94. Middle East and Africa Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
    Table 95. Middle East and Africa Dermatology OTC Medications Revenue by Type (2016-2021) & (US$ Million)
    Table 96. Middle East and Africa Dermatology OTC Medications Revenue by Type (2022-2027) & (US$ Million)
    Table 97. Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
    Table 98. Middle East and Africa Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
    Table 99. Middle East and Africa Dermatology OTC Medications Revenue by Application (2016-2021) & (US$ Million)
    Table 100. Middle East and Africa Dermatology OTC Medications Revenue by Application (2022-2027) & (US$ Million)
    Table 101. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
    Table 102. Middle East and Africa Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
    Table 103. Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million)
    Table 104. Middle East and Africa Dermatology OTC Medications Revenue by Country (2022-2027) & (US$ Million)
    Table 105. Bayer Corporation Information
    Table 106. Bayer Description and Major Businesses
    Table 107. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 108. Bayer Dermatology OTC Medications Product
    Table 109. Bayer Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. GSK Dermatology OTC Medications Product
    Table 114. GSK Recent Developments
    Table 115. Teva Corporation Information
    Table 116. Teva Description and Major Businesses
    Table 117. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Teva Dermatology OTC Medications Product
    Table 119. Teva Recent Developments
    Table 120. Johnson & Johnson Corporation Information
    Table 121. Johnson & Johnson Description and Major Businesses
    Table 122. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Johnson & Johnson Dermatology OTC Medications Product
    Table 124. Johnson & Johnson Recent Developments
    Table 125. Novartis Corporation Information
    Table 126. Novartis Description and Major Businesses
    Table 127. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Novartis Dermatology OTC Medications Product
    Table 129. Novartis Recent Developments
    Table 130. Mylan Corporation Information
    Table 131. Mylan Description and Major Businesses
    Table 132. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. Mylan Dermatology OTC Medications Product
    Table 134. Mylan Recent Developments
    Table 135. Sun Pharmaceutical Corporation Information
    Table 136. Sun Pharmaceutical Description and Major Businesses
    Table 137. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. Sun Pharmaceutical Dermatology OTC Medications Product
    Table 139. Sun Pharmaceutical Recent Developments
    Table 140. Aurobindo Corporation Information
    Table 141. Aurobindo Description and Major Businesses
    Table 142. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Aurobindo Dermatology OTC Medications Product
    Table 144. Aurobindo Recent Developments
    Table 145. Galderma Corporation Information
    Table 146. Galderma Description and Major Businesses
    Table 147. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 148. Galderma Dermatology OTC Medications Product
    Table 149. Galderma Recent Developments
    Table 150. CR SANJIU Corporation Information
    Table 151. CR SANJIU Description and Major Businesses
    Table 152. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 153. CR SANJIU Dermatology OTC Medications Product
    Table 154. CR SANJIU Recent Developments
    Table 155. Dr. Reddy's Corporation Information
    Table 156. Dr. Reddy's Description and Major Businesses
    Table 157. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Dr. Reddy's Dermatology OTC Medications Product
    Table 159. Dr. Reddy's Recent Developments
    Table 160. Lupin Corporation Information
    Table 161. Lupin Description and Major Businesses
    Table 162. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. Lupin Dermatology OTC Medications Product
    Table 164. Lupin Recent Developments
    Table 165. Bausch Health Corporation Information
    Table 166. Bausch Health Description and Major Businesses
    Table 167. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. Bausch Health Dermatology OTC Medications Product
    Table 169. Bausch Health Recent Developments
    Table 170. Cipla Corporation Information
    Table 171. Cipla Description and Major Businesses
    Table 172. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 173. Cipla Dermatology OTC Medications Product
    Table 174. Cipla Recent Developments
    Table 175. Qilu Pharmaceutical Corporation Information
    Table 176. Qilu Pharmaceutical Description and Major Businesses
    Table 177. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 178. Qilu Pharmaceutical Dermatology OTC Medications Product
    Table 179. Qilu Pharmaceutical Recent Developments
    Table 180. Almirall Corporation Information
    Table 181. Almirall Description and Major Businesses
    Table 182. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 183. Almirall Dermatology OTC Medications Product
    Table 184. Almirall Recent Developments
    Table 185. Lingrui Corporation Information
    Table 186. Lingrui Description and Major Businesses
    Table 187. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 188. Lingrui Dermatology OTC Medications Product
    Table 189. Lingrui Recent Developments
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. Dermatology OTC Medications Distributors List
    Table 193. Dermatology OTC Medications Customers List
    Table 194. Dermatology OTC Medications Market Trends
    Table 195. Dermatology OTC Medications Market Drivers
    Table 196. Dermatology OTC Medications Market Challenges
    Table 197. Dermatology OTC Medications Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dermatology OTC Medications Product Picture
    Figure 2. Global Dermatology OTC Medications Market Share by Type in 2020 & 2027
    Figure 3. External Use Product Picture
    Figure 4. Oral Product Picture
    Figure 5. Global Dermatology OTC Medications Sales Market Share by Application in 2020 & 2027
    Figure 6. Hospital
    Figure 7. Drug Store
    Figure 8. Other
    Figure 9. Dermatology OTC Medications Report Years Considered
    Figure 10. Global Dermatology OTC Medications Sales 2016-2027 (M Units)
    Figure 11. Global Dermatology OTC Medications Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Dermatology OTC Medications Revenue 2016-2027 (US$ Million)
    Figure 13. Global Dermatology OTC Medications Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 14. Global Dermatology OTC Medications Sales Market Share by Region (2016-2021)
    Figure 15. Global Dermatology OTC Medications Sales Market Share by Region (2022-2027)
    Figure 16. North America Dermatology OTC Medications Sales YoY (2016-2027) & (M Units)
    Figure 17. North America Dermatology OTC Medications Revenue YoY (2016-2027) & (US$ Million)
    Figure 18. Europe Dermatology OTC Medications Sales YoY (2016-2027) & (M Units)
    Figure 19. Europe Dermatology OTC Medications Revenue YoY (2016-2027) & (US$ Million)
    Figure 20. Asia-Pacific Dermatology OTC Medications Sales YoY (2016-2027) & (M Units)
    Figure 21. Asia-Pacific Dermatology OTC Medications Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Latin America Dermatology OTC Medications Sales YoY (2016-2027) & (M Units)
    Figure 23. Latin America Dermatology OTC Medications Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Middle East & Africa Dermatology OTC Medications Sales YoY (2016-2027) & (M Units)
    Figure 25. Middle East & Africa Dermatology OTC Medications Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. The Top 10 and Top 5 Players Market Share by Dermatology OTC Medications Sales in 2020
    Figure 27. The Top 10 and Top 5 Players Market Share by Dermatology OTC Medications Revenue in 2020
    Figure 28. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 29. Global Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 30. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 31. Global Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 32. Global Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 33. North America Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 34. North America Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 35. North America Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 36. North America Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 37. North America Dermatology OTC Medications Sales Share by Country (2016-2027)
    Figure 38. North America Dermatology OTC Medications Revenue Share by Country (2016-2027)
    Figure 39. U.S. Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 40. Canada Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 41. Europe Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 42. Europe Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 43. Europe Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 44. Europe Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 45. Europe Dermatology OTC Medications Sales Share by Country (2016-2027)
    Figure 46. Europe Dermatology OTC Medications Revenue Share by Country (2016-2027)
    Figure 47. Germany Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 48. France Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 49. U.K. Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 50. Italy Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 51. Russia Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 52. Asia Pacific Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 53. Asia Pacific Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 55. Asia Pacific Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Dermatology OTC Medications Sales Share by Region (2016-2027)
    Figure 57. Asia Pacific Dermatology OTC Medications Revenue Share by Region (2016-2027)
    Figure 58. China Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 59. Japan Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 60. South Korea Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 61. India Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 62. Australia Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 63. Taiwan Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 64. Indonesia Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 65. Thailand Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 66. Malaysia Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 67. Philippines Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 68. Latin America Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 69. Latin America Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 70. Latin America Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 71. Latin America Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 72. Latin America Dermatology OTC Medications Sales Share by Country (2016-2027)
    Figure 73. Latin America Dermatology OTC Medications Revenue Share by Country (2016-2027)
    Figure 74. Mexico Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 75. Brazil Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 76. Argentina Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 77. Middle East and Africa Dermatology OTC Medications Sales Market Share by Type (2016-2027)
    Figure 78. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Dermatology OTC Medications Sales Market Share by Application (2016-2027)
    Figure 80. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Dermatology OTC Medications Sales Share by Country (2016-2027)
    Figure 82. Middle East and Africa Dermatology OTC Medications Revenue Share by Country (2016-2027)
    Figure 83. Turkey Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 84. Saudi Arabia Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 85. U.A.E Dermatology OTC Medications Revenue (2016-2027) & (US$ Million)
    Figure 86. Dermatology OTC Medications Value Chain
    Figure 87. Dermatology OTC Medications Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Frequently Asked Questions
Dermatology OTC Medications report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dermatology OTC Medications report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dermatology OTC Medications report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Coated Abrasive

Coated Abrasive market is segmented by Type, and by Application. Players, stakeholders, and other ... Read More

Phosphate

Phosphate market is segmented by Type, and by Application. Players, stakeholders, and other parti ... Read More

Depaneling Machine

Depaneling Machine market is segmented by Type, and by Application. Players, stakeholders, and ot ... Read More